GREY:ATBPF - Post by User
Comment by
JohnEnglishon Apr 04, 2015 6:41pm
97 Views
Post# 23597585
RE:RE:Re:test studies
RE:RE:Re:test studiesI wasn't bashing, I just pointed out that the preliminary studies were being held prior to the phase 2 tirals as some seemed to be suggesting that phase 2 was gong ahead. My understnding from the M|Partners report is that first they'll do the validating studies and then, depending on their outcome, they'll run the phase 2 trials.
My, hypothetical, question was what happens if the validating studies show that there isn't any dramatic benefit to ATB-346 at the lower dosage? Anyway, we'l have to wait and see.
To whoever said that ATB-346 is just naproxen, that's true but GI tract bleeding related to pain killer medication is one of the biggest killers and causes of complications to people post surgery. So something like ATB-346 that is just as effective as naproxen but without the GI bleeding issue would be a huge deal to doctors and sugeons all over the world.